ABIM Laboratory Reference Ranges January 2015

Laboratory Test

Reference Range

1,25-Dihydroxyvitamin D (1,25-dihydroxycholecalciferol),
serum
11- Deoxycortisol, plasma
Basal
After metyrapone
17-Hydroxycorticosteroids (Porter-Silber), urine
17-Hydroxyprogesterone, serum
Female, Follicular
Female, Luteal
Female. Postmenopausal
Male (adult)
1,5-anhydroglucitol
17-Ketosteroids, urine
25-Hydroxyvitamin D (25-Hydroxycholecalciferol), serum

See Vitamin D metabolites

5-Hydroxyindoleacetic acid, urine

5'-Nucleotidase, serum
6-Thioguanine, whole blood
Absolute neutrophil count (ANC)
Acid phosphatase, serum
Total
Prostatic fraction
ACTH, plasma
Activated partial thromboplastin time

29 mg/24 hr
0.32.6 (Bodansky) units/dL

ADAMTS13 activity
Adrenocorticotropin hormone (ACTH), plasma
Albumin, serum
Albumin, urine
Albumin-to-creatinine ratio, urine
Aldolase, serum
Aldosterone, plasma
Supine or seated
Standing
Low-sodium diet (supine)
Aldosterone, urine
Alkaline phosphatase, serum

Greater than 60%

1060 pg/mL
3.55.5 g/dL
Less than 25 mg/24 hr
Less than 30 mg/g
0.83.0 IU/mL

Alkaline phosphatase, bone specific

Alpha1-antitrypsin (AAT), serum
Alpha2-antiplasmin activity
Alpha-amino nitrogen, urine
Alpha-fetoprotein, serum
Amino acids, urine
Aminotransferase, serum alanine (ALT, SGPT)
Aminotransferase, serum aspartate (AST, SGOT)
Ammonia, blood
Amylase, serum
Amylase, urine

5.618.0 ug/L for premenopausal women

150350 mg/dL
75%115%
100290 mg/24 hr
Less than 10 ng/mL
200400 mg/24 hr
1040 U/L
1040 U/L
4070 g/dL
25125 U/L (80180 [Somogyi] units/dL)
117 U/hr

Less than 1 g/dL

Greater than 10 g/dL
Female: 28 mg/24 hr; male: 310 mg/24 hr
0.20.8 ng/mL
0.83.0 ng/mL
0.040.5 ng/mL
0.21.8 ng/mL
Female: 6.829.3 mcg/mL; male: 10.732 mcg/mL
Female: 515 mg/24 hr; male: 1025 mg/24 hr
See Vitamin D metabolites

230400 pmol/8x108 RBCs

20008250/L
0.52.0 (Bodansky) units/mL
0.10.4 unit/mL
1060 pg/mL
2535 seconds

Up to 10 ng/dL
Less than 21 ng/dL
Up to 30 ng/dL
519 g/24 hr
30120 U/L

Androstenedione, serum
Angiotensin-converting enzyme, serum
Antibodies to double-stranded DNA
Anticardiolipin antibodies
IgG
IgM

Female: 30 200 ng/dL; male: 40-150 ng/dL

853 U/L
07 IU/mL

Anti-cyclic citrullinated peptide, antibodies to

Antideoxyribonuclease B

Less than 20 units

Less than 280 units

Anti-F-actin antibodies, serum

Antihistone antibodies

1:80 or less
Less than 1:16

Anti-LKM
Antimitochondrial antibodies

Less than 1:20

1:5 or less

Antimyelin associated glycoprotein antibody

Antimyeloperoxidase
Antinuclear antibodies
Antismooth muscle antibodies
Antistreptolysin O titer
Antithrombin activity
Antithyroglobulin antibodies
Antithyroid peroxidase antibodies
Arterial blood gas studies (patient breathing room air):

Less than 1:1600

Less than 3.0 U/mL
1:40 or less
1:80 or less
Less than 200 Todd units
80%120%
Less than 20 U/mL
Less than 2.0 U/mL

pH
PaCO2
PaO2
Bicarbonate
Oxygen saturation
Ascorbic acid (vitamin C), blood
Ascorbic acid, leukocyte

7.387.44
3842 mm Hg
75100 mm Hg
2326 mEq/L
95% or greater
0.41.5 mg/dL
16.5 5.1 mg/dL of leukocytes

Beta 1,3-D glucan

Beta subunit chorionic gonadotropin, urine
Beta2-glycoprotein antibodies:

Less than 60 pg/mL

Less than 2 mIU/24 hr

IgG
IgM
Beta-human chorionic gonadotropin, serum
Beta2-microglobulin, serum
Bicarbonate, serum
Bilirubin, serum
Total
Direct
Indirect
Bleeding time (template)
B-type natriuretic peptide, plasma
C peptide, serum
Calcitonin, serum
Calcium, ionized, serum
Calcium, serum
Calcium, urine

Less than 21 SGU

Less than 21 SMU
Less than 3 mIU/mL
0.542.75 mg/L
2328 mEq/L

Carbohydrate antigens, serum

CA 19-9

Less than 20 GPL

Less than 20 MPL

0.31.0 mg/dL
0.10.3 mg/dL
0.20.7 mg/dL
Less than 8 minutes
Less than 100 pg/mL
0.83.1 ng/mL
Female: 5 pg/mL or less; male: 10 pg/mL or less
1.121.23 mmol/L
8.610.2 mg/dL
Female: Less than 250 mg/24 hr; male: less than 300 mg/24
hr
037 U/mL

CA 27-29
CA 125
Carbon dioxide content, serum
Carboxyhemoglobin, blood
Carcinoembryonic antigen, plasma
Carotene, serum
Catecholamines, plasma
Dopamine
Epinephrine
Supine
Standing
Norepinephrine
Supine
Standing
Catecholamines, urine
Dopamine
Epinephrine
Norepinephrine
Total
CD4 (T4) lymphocyte count
Cell count, CSF
Ceruloplasmin, serum (plasma)
Chloride, CSF
Chloride, serum
Chloride, urine
Spot
24-hour measurement
Cholesterol, serum
Total
Desirable
Borderline-high
High
High-density lipoprotein
Low
Low-density lipoprotein
Optimal
Near-optimal
Borderline-high
High
Very high
Cholinesterase, serum (pseudocholinesterase)
Packed cells
Chorionic gonadotropin, human (hCG), serum

Chromogranin A, serum
Citrate, urine
Clotting time (Lee-White)
Coagulation factors, plasma
Factor I (fibrinogen)
Factor II (prothrombin)

Less than 38.0 U/mL

Less than 35 U/mL
2330 mEq/L
Less than 5%
Less than 2.5 ng/mL
75300 g/dL
Less than 30 pg/mL
Less than 50 pg/mL
Less than 95 pg/mL
112658 pg/mL
2171109 pg/mL
65-400 g/24 hr
224 g/24 hr
15100 g/24 hr
26121 g/24 hr
5301570/L
05 cells/L
2543 mg/dL
120130 mEq/L
98106 mEq/L
Varies with intake
mEq/L; varies
mEq/24 hr; varies with intake

Less than 200 mg/dL

200239 mg/dL
Greater than 239 mg/dL
Female: less than 50 mg/dL; male: less than 40 mg/dL
Less than 100 mg/dL
100129 mg/dL
130159 mg/dL
160189 mg/dL
Greater than 189 mg/dL
0.5 or more pH units/hr
0.7 or more pH units/hr
Female, premenopausal nonpregnant: less than 1.0 U/L ;
female, postmenopausal: less than 7.0 U/L; male: less than
1.4 U/L
Less than 93 ng/mL
2501000 mg/24 hr
515 minutes
200-400 mg/dL
60%130%

Factor V (accelerator globulin)

Factor VII (proconvertin)
Factor VIII (antihemophilic globulin)
Factor IX (plasma thromboplastin component)
Factor X (Stuart factor)
Factor XI (plasma thromboplastin antecedent)
Factor XII (Hageman factor)
Cold agglutinin titer
Complements, serum
C3
C4
CH50
Copper, serum
Copper, urine
Coproporphyrin, urine
Cortisol (free), urine
Cortisol, plasma
8 AM
4 PM
1 hour after cosyntropin
Overnight suppression test (1-mg)
Overnight suppression test (8-mg)
Cortisol , saliva, 11 PM - midnight
C-reactive protein
C-reactive protein (high sensitivity), serum
Creatine kinase, serum
Total
MB isoenzymes
Creatine, urine
Creatinine clearance, urine
Creatinine, serum
Creatinine, urine
Spot
24-hour measurement
C-terminal telopeptide of type I collagen (CTx)
Cyclosporine, whole blood (trough)
Therapeutic range
0-3 months post-transplantation
More than 3 months post-transplantation
D-dimer, plasma
Dehydroepiandrosterone sulfate (DHEA-S), serum
Delta-aminolevulinic acid, serum
Digoxin, serum
Dihydrotestosterone, serum
Dopamine, plasma
Dopamine, urine
D-Xylose absorption (after ingestion of 25 g of D-xylose)
Serum

60%130%
60%130%
50%-150%
60%130%
60%130%
60%130%
60%130%
Greater than 1:64 positive
100233 mg/dL
1448 mg/dL
110190 units/mL
100200 g/dL
0100 g/24 hr
50250 g/24 hr
450 g/24 hr
525 g/dL
Less than 10 g/dL
18 g/dL or greater
Less than 1.8 g/dL
Greater than 50% reduction in cortisol
Less than 0.09 mcg/dL
0.8 mg/dL or less
Low risk = less than 1.0 mg/L; Average risk = 1.0-3.0 mg/L;
High risk = more than 3.0 mg/L
Female: 30135 U/L; male: 55170 U/L
Less than 5% of total
Female: 0100 mg/24 hr; male: 040 mg/24 hr
90140 mL/min
0.71.5 mg/dL
mg/dL; varies
1525 mg/kg body weight/24 hr
Greater than 25 pg/mL
100200 ng/mL
150250 ng/mL
75125 mg/mL
Less than 0.5 g/mL
Female: 44332 g/dL; male: 89457 g/dL
Less than 20 g/dL
Therapeutic range: 1.02.0 ng/mL (less than 1.2 ng/mL for
patients with heart failure)
Adult male: 2580 ng/dL
Less than 30 pg/mL
65-400 g/24 hr

2540 mg/dL

Urinary excretion
Electrolytes, serum
Sodium
Potassium
Chloride
Bicarbonate
Epinephrine, plasma
Supine
Standing
Epinephrine, urine
Erythrocyte count
Erythrocyte sedimentation rate (Westergren)
Erythrocyte survival rate (51Cr)
Erythropoietin, serum
Estradiol, serum
Female, Follicular
Mid-cycle peak
Luteal
Postmenopausal
Male
Estriol, urine
Estrogen receptor protein

4.57.5 g during a 5-hr period

136145 mEq/L
3.55.0 mEq/L
98106 mEq/L
2328 mEq/L
Less than 110 pg/mL
Less than 140 pg/mL
Less than 20 g/24 hr
4.25.9 million/L
Female: 020 mm/hr; male: 015 mm/hr
T = 28 days
426 mU/mL
10180 pg/mL
100300 pg/mL
40200 pg/mL
Less than 10 pg/mL
2050 pg/mL
Greater than 12 mg/24 hr
Less than 10 fmol/mg protein is negative

Estrone, serum
Ethanol, blood
Coma level
Intoxication
Euglobulin clot lysis time
Everolimus, whole blood (trough)

1060 pg/mL
Less than 0.005% (less than 5 mg/dL)
More than 0.5%
80100 mg/dL or greater
24 hours at 37.0 C
Therapeutic range: 3.0-8.0 ng/mL

Factor XIII, b subunit

Fecal fat
Fecal nitrogen
Fecal pH
Fecal potassium
Fecal sodium
Fecal urobilinogen
Fecal weight
Ferritin, serum
Fibrin(ogen) degradation products
Fibrinogen, plasma

60130 U/dL
Less than 7 g/24 hr
Less than 2 g/24 hr
7.07.5
Less than 10 mEq/L
Less than 10 mEq/L
40280 mg/24 hr
Less than 250 g/24 hr
Female: 11211 ng/mL; male: 20235 ng/mL
Less than 10 g/mL
200400 mg/dL

Fibroblast growth factor-23, serum

Flecainide, serum
Folate, red cell
Folate, serum
Follicle-stimulating hormone, serum
Female, Follicular/Luteal
Female, Mid-cycle peak
Female, Postmenopausal
Male (adult)
Children, Tanner stages 1,2
Children, Tanner stages 3, 4, 5

3080 RU/mL
Therapeutic range: 0.2-1.0 g/mL
150450 ng/mL of packed cells
1.89.0 ng/mL
29 mIU/mL (29 U/L)
422 mIU/mL (422 U/L)
Greater than 30 mIU/mL (Greater than 30 U/L)
17 mIU/mL (17 U/L)
0.58.0 mIU/mL (0.58.0 U/L)
112 mIU/mL (112 U/L)

Free kappa, serum

Free kappa-to-free lambda ratio, serum
Free lambda, serum
Fructosamine
Gamma globulin, CSF
Gamma-glutamyl transpeptidase, serum
Gastric secretion
Basal acid analysis
Basal acid output
Maximal output after pentagastrin stimulation
Gastrin, serum
Gentamicin, serum
Glucose, CSF
Glucose, plasma (fasting)
Glucose-6-phosphate dehydrogenase, blood
Glycoprotein -subunit, serum
Growth hormone, serum
At rest
Response to provocative stimuli
Haptoglobin, serum
Hematocrit, blood
Hemoglobin A1C
Hemoglobin, blood
Hb A
Hb A2
Hb F
Hemoglobin, plasma

3.319.4 mg/L
0.261.65
5.726.3 mg/L
175280 mmol/L
6.18.3 mg/dL
Female: 840 U/L; male: 950 U/L
1030 units of free acid
Female: 2.0 1.8 mEq of HCl/hr; male: 3.0 2.0 mEq of
HCl/hr
23 5 mEq of HCl/hr
Less than 100 pg/mL
Therapeutic range: peak 5.010.0 mg/dL; trough: less than
2.0 mg/dL
5075 mg/dL
7099 mg/dL
515 units/g of hemoglobin
Less than 1 ng/mL
Less than 5 ng/mL
Greater than 7 ng/mL
83267 mg/dL
Female: 37%47%; male: 42%50%
4.0%5.6%
Female: 1216 g/dL; male: 1418 g/dL
96%98%
1.5%3.5%
Less than 1%
Less than 5.0 mg/dL

Heparinplatelet factor 4 antibody

Hepatic copper

Greater than 0.4 optical density units is positive

2540 g/g dry weight

Hepatic iron index

Histamine excretion, urine
HIV RNA viral load, plasma
Homocysteine, plasma
Human chorionic gonadotropin (hCG), serum

Less than 1.0

2050 g/24 hr
Less than 20 copies/mL
515 mol/L
Female, premenopausal nonpregnant: less than 1.0 U/L ;
female, postmenopausal: less than 7.0 U/L; male: less than
1.4 U/L
1030 mg/sq meter of body surface/24 hr

Hydroxyproline, urine
IGF-I (somatomedin-C), serum
Ages 16-24
Ages 25-39
Ages 40-54
Ages 55 and older
Immune complexes, serum
Immunoglobulins, serum
IgA
IgE
IgG
IgM
Insulin, serum (fasting)

182780 ng/mL
114492 ng/mL
90360 ng/mL
71290 ng/mL
050 g/dL
90325 mg/dL
Less than 380 IU/mL
8001500 mg/dL
45150 mg/dL
Less than 20 U/mL

Iron, serum
Iron-binding capacity, serum (total)
Lactate dehydrogenase, serum
Lactate, arterial blood

50150 g/dL
250310 g/dL
80225 U/L
Less than 1.3 mmol/L (Less than 1.3 mEq/L)

Lactate, serum
Lactate, venous blood
Lactic acid, serum
Lactose tolerance test, GI
Lead, blood
Lead, urine
Leukocyte count
Segmented neutrophils
Band forms
Lymphocytes
Monocytes
Basophils
Eosinophils
Lipase, serum

0.7-2.1 mmol/L
0.61.8 mEq/L; 616 mg/dL
619 mg/dL (0.72.1 mmol/L)
Increase in plasma glucose: greater than 15 mg/dL
1540 g/dL
Less than 80 g/24 hr
400011,000/ L
50%70%
05%
30%45%
06%
01%
03%
10140 U/L

Lipoprotein(a) serum
Lithium, plasma
Therapeutic range
Toxic level
Luteinizing hormone (LH), serum
Female, Follicular/Luteal
Female, Mid-cycle peak
Female, Postmenopausal
Male (adult)
Children, Tanner stages 1, 2, 3
Children, Tanner stages 4, 5
Lymphocyte subsets
CD3
CD4
CD8
CD 19 B
Magnesium, serum
Magnesium, urine
Mean corpuscular hemoglobin
Mean corpuscular hemoglobin concentration
Mean corpuscular volume
Mean platelet volume

Desirable: less than 30 mg/dL

Metanephrines, fractionated, plasma

Metanephrine
Normetanephrine
Metanephrines, fractionated, 24-hour urine
Metanephrine
Normetanephrine
Mixed venous oxygen saturation
Myoglobulin, serum
Norepinephrine, plasma
Supine

0.61.2 mEq/L
Greater than 2 mEq/L
112 mIU/mL (112 U/L)
980 mIU/mL (980 U/L)
Greater than 30 mIU/mL (Greater than 30 U/L)
29 mIU/mL (29 U/L)
Less than 9.0 mIU/mL (Less than 9.0 U/L)
115 mIU/mL (115 U/L)
9003245/L
5301570/L
4301060/L
208590/L
1.62.6 mEq/L
14290 mg/24 hr
2832 pg
3336 g/dL
8098 fL
79 fL
Less than 0.5 nmol/L
Less than 0.9 nmol/L
Less than 400 mcg/24 hr
Less than 900 mcg/24 hr
72%78%
Less than 100 g/L
70750 pg/mL

Standing
Norepinephrine, urine

2001700 pg/mL
0100 g/24 hr

Normetanephrine, fractionated, plasma

Normetanephrine, fractionated, 24-hour urine
N-telopeptide, urine

Less than 0.9 nmol/L

Less than 900 mcg
Female: 1148 nmol/nmol creatinine; male: 768 nmol/nmol
creatinine
275295 mOsm/kg H2O
381400 mOsm/kg H2O
Increased if hemolysis occurs in over 0.5% NaCl; decreased if
hemolysis is incomplete in 0.3% NaCl
Male: 11.335.4 ng/mL; Female: 7.227.9 ng/mL
Less than 40 mg/24 hr

Osmolality, serum
Osmolality, urine
Osmotic fragility of erythrocytes
Osteocalcin, serum
Oxalate, urine
Oxygen consumption
Oxygen saturation, arterial blood
Parathyroid hormone, serum
C -terminal
Intact
Intact (dialysis patients only)
Parathyroid hormone-related protein, serum
Partial thromboplastin time (activated)
pH, urine
Phenobarbital, serum
Phenolsulfonphthalein, urine

Phenytoin, serum
Phosphatase (acid), serum
Total
Prostatic fraction
Phosphatase (alkaline), serum
Phospholipids, serum (total)
Phosphorus, serum
Phosphorus, urine
Platelet count
Platelet survival rate (51Cr)
Potassium, serum
Potassium, urine
Spot
24-hour measurement
Prealbumin, serum
Pregnanetriol, urine

225275 mL/min
95% or greater
150350 pg/mL
1065 pg/mL
target: 130585 pg/mL
Less than 1.5 pmol/L
2535 seconds
4.58.0
Therapeutic range: 25 mg/dL
At least 25% excreted by 15 minutes;
40% by 30 minutes;
60% by 120 minutes
Therapeutic range: 1020 g/mL
0.52.0 (Bodansky) units/mL
0.10.4 unit/mL
30120 U/L
200300 mg/dL
3.04.5 mg/dL
5001200 mg/24 hr
150,000300,000/L
10 days
3.55.0 mEq/L
Varies with intake
mEq/L; varies
mEq/24 hr; varies with intake
1630 mg/dL
0.23.5 mg/24 hr

Pressure (opening) [initial], CSF

Progesterone, serum
Female, Follicular
Female, Luteal
Male (adult)

70180 mm CSF (70180 mm H 2 O)

Proinsulin, serum
Prolactin, serum

320 pmol/L
Less than 20 ng/mL

Prostate specific antigen, serum

no specific normal or abnormal level

65150%
70140%

Protein C activity
Protein C antigen

0.020.9 ng/mL
230 ng/mL
0.120.3 ng/mL

Protein catabolic rate, urine

Protein excretion, urine
Protein S activity
Protein S antigen
Total
Free
Protein, urine
Spot
24-hour measurement

goal: 1.01.2 g/kg/24 hr

50150 mg
57131%

Proteins, CSF total

Proteins, serum
Total
Albumin
Globulin
Alpha1
Alpha2
Beta
Gamma
Protein-to-creatinine ratio, urine
Prothrombin time, plasma
Pyruvic acid, blood
Quinidine, serum
Red cell distribution width (RDW)
Red cell mass
Renin activity (angiotensin-I radioimmunoassay)
Peripheral plasma
Normal diet
Supine
Upright
Low sodium diet
Supine
Upright
Diuretics + low sodium diet
Renal vein concentration
Reptilase time
Reticulocyte count

1545 mg/dL

Reticulocyte count, absolute

Rheumatoid factor (nephelometry)
Rheumatoid factor, latex test for
Ristocetin cofactor activity of plasma

25,000-100,000/uL
Less than 24 IU/mL
1:80 or less
50%150%

Russell viper venom time, dilute

Salicylate, plasma
Sex hormone-binding globulin
Sodium, serum
Sodium, urine
Spot
24-hour measurement
Specific gravity, urine
Sperm density
Sweat test for sodium and chloride

3344 seconds
Therapeutic range: 2030 mg/dL
Female, nonpregnant: 18144 nmol/L; male: 1057 nmol/L
136145 mEq/L

60140%
60130%
mg/dL; varies
Less than 100 mg/24 hr

5.59.0 g/dL
3.55.5 g/dL
2.03.5 g/dL
0.20.4 g/dL
0.50.9 g/dL
0.61.1 g/dL
0.71.7 g/dL
Less than 0.2
1113 seconds
0.080.16 mmol/L
Therapeutic range: 25 g/mL
9.014.5
Female: 22.727.9 mL/kg; male: 24.932.5 mL/kg

0.32.5 ng/mL/hr
0.23.6 ng/mL/hr
0.94.5 ng/mL/hr
4.19.1 ng/mL/hr
6.313.7 ng/mL/hr
Normal ratio (high:low): less than 1.5
1012 seconds
0.5%1.5% of red cells

mEq/L; varies
mEq/24 hr; varies with intake
1.0021.030
10150 million/mL
Less than 60 mEq/L

T3 resin uptake
T4 (CD4) lymphocyte count
Tacrolimus, whole blood
Testosterone, serum
Testosterone, serum (free)
Theophylline, serum
Thrombin time
Thyroid function studies
T3 resin uptake
Thyroglobulin, serum
Thyroidal iodine (123I) uptake
Thyroid-stimulating hormone (TSH), serum
Thyroid-stimulating immunoglobulin (TSI)
Thyroxine binding globulin
Thyroxine index, free (estimate)
Thyroxine (T4), serum
Total
Free
Triiodothyronine (T3), serum
Total
Reverse
Free

25%35%
5301570/L
trough therapeutic range: 515 ng/mL {For transplant
patients: 10.015.0 ng/mL (03 months posttransplantation);5.010.0 ng/mL (more than 3 months posttransplantation)}
Female: 1854 ng/dL; male: 2911100 ng/dL
Male: 70300 pg/mL
Therapeutic range: 820 g/mL
1723 seconds
25%35%
Less than 20 ng/mL
530% of administered dose at 24 hours
0.54.0 U/mL (0.54.0 mU/L)
Less than 130%
1227 mcg/mL
512
512 g/dL
0.81.8 ng/dL
80180 ng/dL
2040 ng/dL
2.34.2 pg/mL

Tobramycin, serum

Therapeutic range: peak 0.52 ug/mL; trough 520 ug/mL

Total proteins, CSF

Transaminase, serum glutamic oxaloacetic (SGOT)
Transaminase, serum glutamic pyruvic (SGPT)
Transferrin saturation
Transferrin, serum
Triglycerides, serum (fasting)
Optimal
Normal
Borderline high
High
Very high
Troponin I, serum cardiac
Troponin T, serum cardiac
Urea clearance, urine
Standard
Maximal
Urea nitrogen, blood
Urea nitrogen, urine
Uric acid, serum
Uric acid, urine
Uroporphyrin, urine

1545 mg/dL
See aminotransferase, serum aspartate (AST)
See aminotransferase, serum alanine (ALT)
20%50%
200400 mg/dL

Vancomycin, plasma
Vancomycin, serum
Vanillylmandelic acid, urine

therapeutic: 15 to 20 mg/L
10 to 16 ug/mL
Less than 9 mg/24 hr

Less than 100 mg/dL

Less than 150 mg/dL
150199 mg/dL
200499 mg/dL
Greater than 499 mg/dL
00.1 ng/mL [g/L]
00.1 ng/mL [g/L]
4060 mL/min
60100 mL/min
820 mg/dL
1220 g/24 hr
3.07.0 mg/dL
250750 mg/24 hr
1030 g/24 hr

Venous oxygen content, mixed

Venous studies, mixed, blood
PO2
PCO2
Bicarbonate
pH
Oxygen saturation
Viscosity, serum
Vitamin B12, serum
Vitamin D metabolites, serum
1,25-Dihydroxyvitamin D (1,25dihydroxycholecalciferol)
25-Hydroxyvitamin D (25-hydroxycholecalciferol)
Volume, blood
Plasma
Red cell
von Willebrand factor antigen
Zinc, serum

1416 mL/dL
3542 mm Hg
4253 mm Hg
2428 mEq/L
7.327.41
65%75%
1.41.8 cp
200800 pg/mL
1560 pg/ml
20-60 ng/mL

Female: 43 mL/kg body weight; male: 44 mL/kg body weight

Female: 2030 mL/kg body weight; male: 2535 mL/kg body
weight
50%150%
75140 g/dL